Login

Balance sheets

In USD, except per-share amounts
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q3 FY2014
As of Sep 30, 2014
Q2 FY2014
As of Jun 30, 2014
Q1 FY2014
As of Mar 31, 2014
Q4 FY2013
As of Dec 31, 2013
Q3 FY2013
As of Sep 30, 2013
Q2 FY2013
As of Jun 30, 2013
Q1 FY2013
As of Mar 31, 2013
Q4 FY2012
As of Dec 31, 2012
Q3 FY2012
As of Sep 30, 2012
Q1 FY2012
As of Mar 31, 2012
Q3 FY2011
As of Sep 30, 2011
ASSETS
Cash
Accounts receivable
Prepaid
Total Assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Liabilities
Related Party Loan
Deferred Gain
Accounts payable and accrued liabilities
Bank overdraft
Due to related party – accounts payable, net
Due to related party – notes payable
Current Liabilities Held for Sale
Due to related party – convertible notes payable
Convertible notes payable, net of discount of $236,107 and $0
Derivative liabilities
Total Current Liabilities
ARO Obligation
Convertible notes payable, net of discount of $88,303 and $0
Total Liabilities
STOCKHOLDERS’ DEFICIT
Common stock, 100,000,000 shares authorized, $0.001 par value; 23,867,679 and 467,679 issued and outstanding as of September 30, 2015 and December 31, 2014, respectively
Additional paid-in capital
Common Stock, payable
Accumulated comprehensive income
Deficit accumulated before re-entry to the the development stage
Accumulated deficit after re-entry to the development stage
Accumulated Deficit
Total Stockholders’ Deficit
Total Liabilities and Stockholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support